Company profile
Maze Therapeutics
At Maze, we envision a world where genetic insights inspire new medicines.
- Industry
- Biotechnology Research
- Employees
- 156
- Headquarters
- South San Francisco, California
- Founded
- 2018
- LinkedIn followers
- 27,677
- Office locations
- 1
Maze Therapeutics company summary
Maze Therapeutics is a company in the Biotechnology Research industry, headquartered in South San Francisco, California, founded in 2018. On LinkedIn the company has around 156 employees and 27,677 followers.
What technology does Maze Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Maze Therapeutics
Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease. Maze is based in South San Francisco.
Where is Maze Therapeutics located?
Maze Therapeutics lists 1 location.
Compare companies similar to Maze Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Maze Therapeutics mazetx.com | Biotechnology Research | 156 | 2018 | South San Francisco, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Maze Therapeutics
What does Maze Therapeutics do?
Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease. Maze is based in South San Francisco.
How many employees does Maze Therapeutics have?
Maze Therapeutics has around 156 employees on LinkedIn.
Where is Maze Therapeutics headquartered?
Maze Therapeutics is headquartered in South San Francisco, California.
When was Maze Therapeutics founded?
Maze Therapeutics was founded in 2018.
Build a lead list from companies like Maze Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.